Showing 1,301 - 1,320 results of 39,746 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( e ((nn decrease) OR (mean decrease)) ))', query time: 1.06s Refine Results
  1. 1301
  2. 1302
  3. 1303
  4. 1304
  5. 1305

    The mean amplitude and standard deviation of the EOD of the swimming fish influence the spectral characteristics of E1. by Na Yu (151735)

    Published 2012
    “…Increasing improves this resolution, whereas the increases in decreases this resolution. Other parameters here are the same as those in the case of two fish in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002564#pcbi-1002564-g003" target="_blank">Figure 3</a>. 50 independent OU process realizations were used to produce theses averaged plots.…”
  6. 1306

    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

    Published 2016
    “…Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2–5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2–0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. …”
  7. 1307

    POm E-stimulation before whisker stimulus does not decrease cortical response magnitude and duration when PTX is applied in L1. by Carlos Castejon (2182382)

    Published 2016
    “…<p>(A) Percentage change in mean response magnitude by POm E-stimulation before (black) and after PTX application (grey). …”
  8. 1308
  9. 1309

    POm E-stimulation before whisker stimulus does not decrease cortical response magnitude and duration when AGA is applied in L1. by Carlos Castejon (2182382)

    Published 2016
    “…<p>(A) Percentage change in mean response magnitude by POm E-stimulation before (black) and after AGA application (grey). …”
  10. 1310
  11. 1311
  12. 1312
  13. 1313
  14. 1314
  15. 1315
  16. 1316
  17. 1317
  18. 1318
  19. 1319

    Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled T... by Chunfeng Qu (114656)

    Published 2014
    “…The estimated efficacy of catch-up vaccination on HBsAg seroprevalence in early adulthood was 21% (95% CI 10%–30%), substantially weaker than that of the neonatal vaccination (72%, 95% CI 68%–75%). Receiving a booster at age 10–14 years decreased HBsAg seroprevalence if participants were born to HBsAg-positive mothers (hazard ratio [HR] = 0.68, 95% CI 0.47–0.97). …”
  20. 1320